Boghuma Kabisen Titanji
Clinical researcher
Boghuma Kabisen Titanji's AcademicInfluence.com Rankings
Download Badge
Medical Philosophy
Boghuma Kabisen Titanji's Degrees
- Bachelors Biology University of Maryland, Baltimore County
Similar Degrees You Can Earn
Why Is Boghuma Kabisen Titanji Influential?
(Suggest an Edit or Addition)According to Wikipedia, Boghuma Kabisen Titanji is a Cameroonian medical doctor and clinical researcher. She is an expert on HIV drug resistant viruses. Education and work Boghuma Kabisen Titanji, clinically trained in Cameroon, received her MSc and DTM&H in Tropical Medicine and International Health from the London School of Hygiene & Tropical Medicine in 2010 and a PhD in Infectious Diseases studying HIV-1 cell-to-cell spread and Antiretroviral therapy drug resistance from University College London in 2014. Titanji's work focuses on the mechanisms of HIV transmission and antiretroviral drug resistance. In May 2012, she gave a TED Talk on the ethics of medical research in Africa.
Boghuma Kabisen Titanji's Published Works
Published Works
- Monkeypox: A Contemporary Review for Healthcare Professionals (2022) (96)
- Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019 (2020) (86)
- Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells (2013) (73)
- Development and Application of a Broadly Sensitive Dried-Blood-Spot-Based Genotyping Assay for Global Surveillance of HIV-1 Drug Resistance (2010) (59)
- Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection (2020) (30)
- Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series (2022) (15)
- Monkeypox (2022) (11)
- Combination antiretroviral therapy and cell–cell spread of wild-type and drug-resistant human immunodeficiency virus-1 (2017) (10)
- Monkeypox—not doing enough is not an option (2022) (7)
- Monkeypox emergency: Urgent questions and perspectives (2022) (6)
- A Diverse Physician-Scientist Pipeline to Fight Structural Racism. (2020) (5)
- #SoMe the Money! Value, Strategy, and Implementation of Social Media Engagement for Infectious Diseases Trainees, Clinicians, and Divisions. (2022) (3)
- Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression (2022) (3)
- Neglecting emerging diseases – monkeypox is the latest price of a costly default (2022) (3)
- Deconstruct racism in medicine — from training to clinical trials (2020) (2)
- Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality (2022) (2)
- Human Monkeypox Virus Infection in Women During the 2022 Outbreaks – a Global Case Series (2022) (2)
- Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club (2022) (2)
- Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al (2020) (1)
- Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas? (2021) (1)
- What’s Hot in HIV in 2019—A Basic and Translational Science Summary for Clinicians From IDWeek 2019 (2020) (1)
- The monkeypox outbreak must amplify hidden voices in the global discourse (2022) (1)
- Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al. (2020) (1)
- Protect the vulnerable from monkeypox (2022) (1)
- Neuromyelitis Optica Presenting as Infectious Meningoencephalitis: Case Report and Literature Review. (2020) (1)
- Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy (2021) (1)
- Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells (2013) (1)
- Cognitively Based Compassion Training for HIV Immune Nonresponders—An Attention-Placebo Randomized Controlled Trial (2021) (1)
- Social Media: Flattening Hierarchies for Women and Black, Indigenous, People Of Color (BIPOC) to Enter the Room Where It Happens. (2022) (0)
- Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19 (2022) (0)
- Soluble CD14-associated DNA methylation sites predict mortality among men with HIV infection (2022) (0)
- Vaxxing to elimination: smallpox vaccines as tools to fight mpox (2023) (0)
- The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable. (2023) (0)
- Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression (2022) (0)
- Utility of a Viral Vesicular Panel Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Monkeypox, Herpes Simplex, and Varicella Zoster Viruses (2023) (0)
- Epigenome-wide association study of biomarkers of liver function identifies albumin-associated DNA methylation sites among male veterans with HIV (2022) (0)
- Creating a best practice template for participant communication plans in global health clinical studies (2023) (0)
- Reply to Jorgensen, et al (2020) (0)
- Breaking barriers: Scientific contributions in virology from women in low- and middle-income countries (2023) (0)
- ARTful ageing: epigenetic rejuvenation in people with HIV (2023) (0)
- Reply to Cerda-Contreras, et al. (2020) (0)
- Exploring the Impact of Antiretroviral Drugs on the Cell-to-Cell spread of HIV-1 (2015) (0)
- Deconstruct racism in medicine — from training to clinical trials (2020) (0)
This paper list is powered by the following services:
Other Resources About Boghuma Kabisen Titanji
What Schools Are Affiliated With Boghuma Kabisen Titanji?
Boghuma Kabisen Titanji is affiliated with the following schools: